Figure 2
Comparison of peripheral blood: (A) Tregs (CD25hi CD127lo, expressed as %age of CD3+ CD4+ T cells) after SAH in patients with cerebral vasospasm (CVS) and without CVS during EBI and DBI phases; (B) HLA-DR− CD38+ Tregs (expressed as %age of CD3+ CD4+ T cells) after SAH in patients with CVS and with no CVS during EBI and DBI phases; (C) HLA-DR− CD38+ Tregs (expressed as %age of CD3+ CD4+ T cells) after SAH in patients with seizures and with no seizures during EBI and DBI phases; (D) HLA-DR− CD38+ Tregs (expressed as %age of CD3+ CD4+ T cells) after SAH in patients with shunt dependent chronic hydrocephalus and with no shunt dependent chronic hydrocephalus during EBI and DBI phases; (E) HLA-DR− CD38− Tregs (expressed as %age of CD3+ CD4+ T cells) after SAH in patients with cerebral ischemia/infarction (CI) and with no CI during EBI and DBI phases; (F) Th1 cells (CXCR3+ CCR6− , expressed as %age of CD3+ CD4+ T cells) after SAH in patients with infections and without infections during EBI and DBI phases; (G) HLA-DR− CD38− Th1 cells (expressed as %age of CD3+ CD4+ T cells) after SAH in patients with infections and without infections during EBI and DBI phases; (H) HLA-DR− CD38+ Tregs (expressed as %age of CD3+ CD4+ T cells) after SAH in patients with infections and without infections during EBI and DBI phases; (I) HLA-DR− CD38+ Tregs (expressed as %age of CD3+ CD4+ T cells) after SAH in patients with IVH and without IVH during EBI and DBI phases. One way ANOVA followed by Tukey’s/Bonferroni's multiple comparisons test for normally distributed data. Kruskal Wallis test followed by Dunn’s multiple comparisons test for non-normally distributed data; A p value < 0.05 was considered as a significant difference. *Indicates a p value < 0.05, **indicates a p value < 0.01, ***indicates a p value < 0.001. EBI early brain injury phase after SAH covering days 1–3 (n = 15), DBI delayed brain injury phase after SAH covering days 7–9 (n = 15).
